UCLA Health Explores Precision Therapies for Ovarian Cancer

Researchers at UCLA Health are developing novel targeted therapies for ovarian cancer, aiming to deliver chemotherapy with greater precision. These clinical trials focus on patients whose tumors express specific proteins, such as claudin-6 or the folate receptor. The initiative seeks to enhance treatment efficacy and improve the quality of life for patients, potentially leading to better long-term prognoses.